Skip to main content

LCD L39956: Total Shoulder Arthroplasty

LCD L39956, Total Shoulder Arthroplasty, is the Local Coverage Determination that Palmetto GBA applies to claims from 7 states (AL, GA, NC, SC, TN, VA, WV), effective 2025-03-27. The policy text runs 570 words, and its billing and coding article A59878 lists 272 ICD-10-CM codes that support medical necessity for 1 procedure code. No other contractor publishes a policy with this title.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
Palmetto GBA
States and territories
7
AL GA NC SC TN VA WV
Revision effective
2025-03-27
Original effective
2025-03-27
Policy text
570 words
Covered ICD-10 codes (articles)
272

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L39956
ContractContractorTypeStates
11201Palmetto GBAA and B and HHH MACSC
11301Palmetto GBAA and B and HHH MACVA
11401Palmetto GBAA and B and HHH MACWV
11501Palmetto GBAA and B and HHH MACNC
11202Palmetto GBAA and B and HHH MACSC
11302Palmetto GBAA and B and HHH MACVA
11402Palmetto GBAA and B and HHH MACWV
11502Palmetto GBAA and B and HHH MACNC
10111Palmetto GBAA and B MACAL
10211Palmetto GBAA and B MACGA
10311Palmetto GBAA and B MACTN
10112Palmetto GBAA and B MACAL
10212Palmetto GBAA and B MACGA
10312Palmetto GBAA and B MACTN

Billing and coding article A59878: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A59878 (Billing and Coding: Total Shoulder Arthroplasty) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

A59878: Billing and Coding: Total Shoulder Arthroplasty (Billing and Coding, effective 2025-03-27)

Covered ICD-10-CM codes
272
1 group
Non-covered ICD-10-CM codes
0
Procedure codes listed
1
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A59878
ICD-10-CMDescription (FY2027)
C40.01Malignant neoplasm of scapula and long bones of right upper limb
C40.02Malignant neoplasm of scapula and long bones of left upper limb
C43.61Malignant melanoma of right upper limb, including shoulder
C43.62Malignant melanoma of left upper limb, including shoulder
C44.602Unspecified malignant neoplasm of skin of right upper limb, including shoulder
C44.609Unspecified malignant neoplasm of skin of left upper limb, including shoulder
C49.11Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder
C49.12Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder
C76.41Malignant neoplasm of right upper limb
C76.42Malignant neoplasm of left upper limb
D03.61Melanoma in situ of right upper limb, including shoulder
D03.62Melanoma in situ of left upper limb, including shoulder
M05.011Felty's syndrome, right shoulder
M05.012Felty's syndrome, left shoulder
M12.011Chronic postrheumatic arthropathy [Jaccoud], right shoulder
M12.012Chronic postrheumatic arthropathy [Jaccoud], left shoulder
M12.511Traumatic arthropathy, right shoulder
M12.512Traumatic arthropathy, left shoulder
M12.811Other specific arthropathies, not elsewhere classified, right shoulder
M12.812Other specific arthropathies, not elsewhere classified, left shoulder
M19.011Primary osteoarthritis, right shoulder
M19.012Primary osteoarthritis, left shoulder
M19.111Post-traumatic osteoarthritis, right shoulder
M19.112Post-traumatic osteoarthritis, left shoulder

Procedure codes: 23472.

Coverage indications, limitations and medical necessity

Indications of Coverage

Total shoulder arthroplasty (TSA) is reasonable and necessary for each of the following conditions:

• Degenerative glenohumeral joint disease including osteoarthritis (OA), OR post-traumatic arthritis, OR rheumatoid arthritis (RA), OR osteonecrosis, OR arthropathy with rotator cuff deficit when all the following are present:

• Documented radiographic evidence of the diagnosis (e.g., irregular joint surfaces, subchondral cysts, glenoid flattening or sclerosis, periarticular osteophytes, joint subluxation, joint space narrowing, or avascular necrosis); AND

• Documentation of moderate-to-severe chronic pain OR chronic functional disability for a minimum of 12 weeks; AND

• Documentation of at least 12 weeks of unsuccessful conservative therapy. (If conservative therapy is not appropriate, the medical record must clearly document why such approach is not reasonable.) 1

• Treatment of acute proximal humerus fractures (PHFs) not amenable to conservative therapy or internal fixation

• Treatment of nonunion or malunion PHFs with radiographic evidence

• Reconstruction following tumor resection of the glenohumeral joint, proximal humerus, or adjacent tissue

• Massive irreparable rotator cuff tears (MIRCTs) when all the following are present:

• Evidence of massive rotator cuff tear (MRCT) by magnetic resonance imaging (MRI) or arthroscopy (e.g., tear size greater than 5 cm in an anterior-posterior or medial-lateral orientation, OR tears of 2 or more tendons, OR retraction of the tendon to the glenoid rim with greater than 2/3 of the greater tuberosity exposed on imaging in the sagittal plane) 2

• Pseudo-paralysis

• Documentation of at least 12 weeks of unsuccessful conservative therapy including 12 weeks of supervised physical therapy (PT). (If conservative therapy is not appropriate, the medical record must clearly document why such approach is not reasonable.)

• Reverse total shoulder arthroplasty (RTSA) following failed anatomic total shoulder arthroplasty (aTSA) or failed hemiarthroplasty (HA)

NOTE: To document unsuccessful conservative therapy, a pain or disability assessment must be performed and documented at baseline and after therapeutic intervention using the same scale for each assessment.

The scales used for measurement of pain or disability must be documented in the medical record. Acceptable scales include but are not limited to: verbal rating scales, Numerical Rating Scale (NRS), Visual Analog Scale (VAS) for pain assessment, Disabilities of the Arm, Shoulder and Hand (DASH), Shoulder Pain and Disability Index (SPADI), American Shoulder and Elbow Surgeon score (ASES), Simple Shoulder Test (SST), Constant-Murley score, and Western Ontario Rotator Cuff Index (WORC).

Limitations of Coverage

Provider Qualifications

The Medicare Program Integrity Manual states services will be considered medically reasonable and necessary only if performed by appropriately trained providers.

Patient safety and quality-of-care mandate that healthcare professionals who perform shoulder arthroplasty are appropriately trained and/or credentialed by a formal residency/fellowship program, and/or are certified by either an accredited and nationally recognized organization, or by a post-graduate training course accredited by an established national accrediting body or accredited professional training program whose core curriculum includes the performance and management of the procedures addressed in this LCD. Credentialing and privileges are required for procedures performed in inpatient and outpatient settings.

Definitions

Conservative therapy: nonoperative treatment that may include 1 or more of the following:

• Anti-inflammatory medications or analgesics

• Flexibility and muscle strengthening exercises

• A trial of supervised PT

• Corticosteroid injections

Pseudo-paralysis: MRCT with active elevation less than 90° against gravity 3,4

Total shoulder arthroplasty (also known as total shoulder replacement): a surgical procedure that replaces both the glenoid and proximal humerus with prosthetic parts. This includes both aTSA and RTSA.

Summary of evidence (opening)

Safety

In 2007, Farmer et al. compared the outcomes of shoulder, hip, and knee arthroplasties. They specifically evaluated the inpatient mortality, complications, length of stay, and total charges of patients who had shoulder arthroplasty for OA with those of patients who had hip and knee arthroplasties for OA. A review of the Maryland Health Services Cost Review Commission discharge database identified 994 shoulder arthroplasties, 15,414 hip arthroplasties, and 34,471 knee arthroplasties performed for OA from 1994 to 2001. They found no in-hospital deaths after shoulder arthroplasty, whereas 27 (0.18%) and 54 (0.16%) deaths occurred after hip and knee arthroplasties, respectively. Compared with patients who had hip or knee arthroplasties, patients who had shoulder arthroplasties had, on average, a lower complication rate, a shorter length of stay, and fewer total charges. The latter had 1/2 as many in-hospital complications, were 1/6 as likely to have a length of stay 6 days or greater and were 1/10 as likely to be charged more than $15,000. They concluded shoulder arthroplasty is as safe as the more commonly performed major joint arthroplasties. 5

Ahmed et al. performed a 2021 retrospective review comparing readmission rates and postoperative complications in outpatient versus inpatient TSA. Ten level III retrospective studies were included with 7,637 (3.8%) and 192,025 (96.2%) patients undergoing outpatient and inpatient TSA, respectively. Outpatient TSA had relatively younger and healthier patients. There were no differences between outpatient and inpatient arthroplasty for 30- and 90-day readmissions. Furthermore, unadjusted comparisons demonstrated significantly less total and major surgical complications and less total, major, and minor medical complications in favor of outpatient TSA. However, subgroup analyses demonstrated that there were no significant differences in all complications if the studies had matched controls and regardless of data source (database or non-database studies). The revision rates were similar between both groups at a 12–24-month follow-up. Two studies reported a significant reduction in costs in favor of outpatient TSA. 6

In 2022, Puzzitiello et al. conducted a systematic review to evaluate the safety and cost of outpatient TSA by assessing associated complication rates, clinical outcomes, and total treatment charges. Of 20 studies identified that met inclusion criteria, 14 were comparative studies involving an inpatient control group, 2 of which were matched by age and comorbidities. The remaining studies used control groups consisting of inpatient TSAs who were older or more medically infirm according to American Society of Anesthesiologists (ASA) or Charlson Comorbidity Index (CCI) scores. The combined average age of the outpatient and inpatient groups was 66.5 and 70.1 years, respectively. Patients who underwent outpatient TSA had similar rates of readmissions, emergency department visits, and perioperative complications in comparison to inpatients. Patients also reported comparably high levels of satisfaction with outpatient procedures. Four economic analyses demonstrated substantial cost savings with outpatient TSA in comparison to inpatient surgery. 7

The contractor cites 27 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2025-03-27
Current revision effective
2025-03-27
Last reviewed by the contractor
2024-10-28
MCD version
5

Other related documents: A59943 (Response to Comments).

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Palmetto GBA hub lists every other active policy from the same contractor.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L39956 cover?

Total shoulder arthroplasty (TSA) is reasonable and necessary for each of the following conditions: The full 570-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L39956 apply to?

Palmetto GBA applies it to Medicare claims in 7 states: AL, GA, NC, SC, TN, VA, WV. It binds only that contractor; outside these jurisdictions the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L39956?

The companion billing and coding article A59878 lists 272 ICD-10-CM codes in 1 group that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L39956?

A denial under LCD L39956 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A59878's 272 covered diagnosis codes, then file a redetermination with Palmetto GBA within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.